期刊文献+

Survivin在人结直肠腺瘤和腺癌组织中的表达 被引量:3

Expression of Survivin in Colorectal Adenoma and Adenocarcinoma
下载PDF
导出
摘要 目的研究Survivin(SVV)在人结直肠腺瘤和腺癌组织中的表达及意义。方法采用免疫组织化学方法检测90例结直肠腺瘤、25例结直肠腺瘤伴重度不典型增生和108例结直肠腺癌组织中SVV、P53和Bcl-2的表达情况。结果SVV在结直肠腺管状腺瘤、绒毛状腺瘤、绒毛腺管状腺瘤等结直肠腺瘤组织中的表达率分别为30%(12/40)、40.9%(9/22)和35.8%(10/28),3组间差异无显著性(P>0.05)。SVV在绒毛腺管状腺瘤组织伴重度不典型增生组织,DukesA、B、C期结直肠腺癌组织中的表达率分别为68%(17/25)、75%(27/36)、81.3%(26/32)和95%(38/40),均明显高于结直肠腺瘤各组(P<0.05)。P53和Bcl-2在上述各组病例组织中的表达差异均无显著性(P>0.05)。SVV的高表达与Bcl-2和P53表达无相关性(P=0.487,P=0.437)。结论SVV在结直肠癌发生早期即有表达异常,可能与结直肠腺瘤癌变具有一定关系。SVV表达对结直肠腺瘤和腺癌的鉴别诊断具有一定意义。 Objective To explore the expression of Survivin (SVV) protein in colorectal carcinogen- esis and its clinical significance. Methods Immunohistochemistry staining was performed by two-step EnVision^TM technique for the paraffin sections, which included 90 adenomas, 25 ademomas with high-grade glandular intraepithelial neoplasia, and 108 colorectal adenocarcinomas. Results Expressions of SVV, P53, and Bcl-2 were observed in tumor cells of the sections. The positive rate of SVV in tubular adenomas, villous adenomas, and tubulovillous adenomas were 30% (12/40) , 40.9% (9/22), and 35.8% (10/28) , respectively. The positive rate of SVV in tubulovillous adenomas with high-grade glandular intraepithelial neoplasia were 68% (17/25). The positive rate of SVV in carcinomas of stage A, B, and C were 75% (27/36) , 81.3% (26/ 32) , and 95% (38/40) , respectively. SVV expressions among the three types of adenomas without neoplasia were not significantly different ( P 〉 0.05 ). SVV expression between each type of the above-mentioned ademoma and tubulovillous adenoma with high-grade glandular intraepithelial neoplasia or different Dukes stages of colorectal carcinoma was significantly different ( P 〈 0. 05 ). SVV expressions in adenocarcinomas and adenomas with high grade glandular intraepithelial neoplasia were significantly higher than those in adenomas ( P 〈 0. 01). The expressions of P53 and Bcl-2 had no significant difference among them. No association was noted between SVV expression and P53 or Bcl-2 expression ( P = 0. 487, P = 0. 437). Conclusions SVV is abnormally expressed in the early stage of colorectal carcinogenesis, which may be correlated with the carcinogenesis of colorectal ademoma. SVV expression may be useful to distinguish adenocarcinoma from adenoma in colorectal carcinogenesis.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2007年第3期398-401,I0009,共5页 Acta Academiae Medicinae Sinicae
基金 首都医学发展基金(2003-3011) 2003年北京协和医院科研基金~~
关键词 SURVIVIN 腺瘤 腺癌 结直肠 Survivin adenoma carcinoma colarectal
  • 相关文献

参考文献13

  • 1Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,survivin expressed in cancer and lymphoma[J].Nature Med,1997,3(8):917-921.
  • 2Adida C,Crotty PL,McGrath J,et al.Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation[J].Am J Pathol,1998,152(1):43-49.
  • 3Adida C,Berrebi D,Peuchmaur M,et al.Anti-apoptosis gene,survivin,and prognosis of neuroblastoma[J].Lancet,1998,351 (9106):882-883.
  • 4杨景,柳凤轩,阎晓初,贺光友,刘丽梅.Survivin在结直肠癌组织中表达的临床意义及其与细胞凋亡、血管生成的关系[J].癌症,2005,24(1):116-120. 被引量:21
  • 5Mosmann T.Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays[J].J Immunol Methods,1983,65(1-2):55-63.
  • 6Monzo M,Rosell R,Felip E,et al.A novel anti-apoptosis gene:re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers[J].J Clin Oncol,1999,17(7):2100-2104.
  • 7Tanaka K,Iwamoto S,Gon G,et al.Expression of survivin and its relationship to loss of apoptosis in breast carcinomas[J].Clin Cancer Res,2000,6(1):127-134.
  • 8关健,陈杰.Survivin——一个新的肿瘤特异性的抑制凋亡因子[J].中国医学科学院学报,2001,23(5):532-534. 被引量:5
  • 9姚红兵,吴爱国,黄宗海.Survivin在结直肠癌中的表达及其临床意义[J].第一军医大学学报,2004,24(12):1412-1415. 被引量:7
  • 10Altieri DC,Marchisio C.Survivin apoptosis:an interloper between cell death and cell proliferation in cancer[J].Lab Invest,1999,79 (11):1327-1333.

二级参考文献9

共引文献29

同被引文献19

  • 1张晓雨,周建农,张彤.survivin、VEGF及Ki67在结直肠癌中的表达及其临床意义[J].肿瘤防治研究,2007,34(1):35-38. 被引量:18
  • 2Ambrosini G, Adida C, Ahieri DC. A novel anti- apoptosis gene, Survivin expressed in cancer and lymphoma [J]. Nature Med, 1997, 3 (8): 917.
  • 3Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti - apoptosis gene Survivin in human and mouse differentiation [ J ]. Am J Pathol, 1998, 152:43.
  • 4Bokarewa M, Lindblad S, Bokarew D, et al. Balance between Surviving, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis [J]. Arthritis Res Ther, 2005, 7 : 349.
  • 5Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti - apoptosis gene Survivin in human and mouse differentiation [ J ]. Am J Pathol, 1998, 152:43.
  • 6Adida C, Berrebi D, Peuchmaur M, et al. Anti - apoptosis gene, Survivin, and prognosis of neuroblastoma [J]. The lancet, 1998, 351:882.
  • 7Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays [J]. J Immunol Methods, 1983, 65:55.
  • 8Monzo M, Rosell R, Felip E, et al. A novel anti -apoptosis gene : Re - expression of Survivin messenger RNA as a prognosis marker in non - small - cell lung cancers [ J ]. J Clin Oncol, 1999, 17 (7): 2100.
  • 9Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas [J]. Clin Cancer Res, 2000, 6 : 127.
  • 10Bria E, Visca P, Novelli F, et al. Nuclear and cytoplasmic cellular distribution of Surviving as survival predictor in resected non -small- cell lung cancer [ J ]. Eur J Surg Oncol, 2008, 34 (5) : 593.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部